Citigroup Inc Meira G Tx Holdings PLC Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Citigroup Inc holds 29,448 shares of MGTX stock, worth $184,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,448

Previous 9,904 197.33%

Holding current value

$184,933

Previous $41,000 197.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.88 - $5.23 $75,830 - $102,215	19,544 Added 197.33%	29,448 $122,000
Q2 2024 Aug 12, 2024	SELL	$4.21 - $5.81 $5,784 - $7,982	-1,374 Reduced 12.18%	9,904 $41,000
Q1 2024 May 10, 2024	SELL	$5.78 - $7.33 $4,074 - $5,167	-705 Reduced 5.88%	11,278 $68,000
Q4 2023 Feb 09, 2024	BUY	$3.6 - $7.15 $24,508 - $48,677	6,808 Added 131.56%	11,983 $84,000
Q3 2023 Nov 09, 2023	SELL	$4.79 - $7.19 $51,559 - $77,393	-10,764 Reduced 67.53%	5,175 $25,000
Q2 2023 Aug 10, 2023	BUY	$5.19 - $8.07 $40,336 - $62,720	7,772 Added 95.16%	15,939 $107,000
Q1 2023 May 11, 2023	SELL	$5.04 - $8.6 $15,593 - $26,608	-3,094 Reduced 27.48%	8,167 $42,000
Q4 2022 Feb 09, 2023	BUY	$5.8 - $8.98 $13,102 - $20,285	2,259 Added 25.09%	11,261 $73,000
Q3 2022 Nov 10, 2022	SELL	$7.55 - $11.25 $19,373 - $28,867	-2,566 Reduced 22.18%	9,002 $76,000
Q2 2022 Aug 10, 2022	SELL	$6.8 - $14.23 $69,795 - $146,056	-10,264 Reduced 47.01%	11,568 $87,000
Q1 2022 May 12, 2022	SELL	$13.42 - $23.38 $145,070 - $252,737	-10,810 Reduced 33.12%	21,832 $303,000
Q4 2021 Feb 10, 2022	SELL	$12.78 - $23.74 $159,187 - $295,705	-12,456 Reduced 27.62%	32,642 $775,000
Q3 2021 Nov 10, 2021	BUY	$11.73 - $16.08 $528,999 - $725,175	45,098 New	45,098 $594,000

Others Institutions Holding MGTX

# of Institutions

100

Shares Held

45.4M

Call Options Held

19.2K

Put Options Held

31K

View Full List

About MeiraGTx Holdings plc

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $283M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

More about MGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account